Adverse Events Associated with CFTR Modulator Therapy: Experience from a Tertiary Care Center. (PubMed, Turk Arch Pediatr) - Oct 3, 2026 - "Cystic fibrosis transmembrane conductance regulator modulators are generally well tolerated in the pediatric population. Most adverse events are mild, transient, and manageable through routine monitoring and temporary cessation, allowing for the safe continuation of therapy."
Adverse events • Journal • Cystic Fibrosis • Dermatology • Genetic Disorders • Immunology • Pediatrics • Pulmonary Disease • Respiratory Diseases • CFTR
|
|
Dilara Demirel; Ebru Güne? Yalç?n
|